Lilly posts Phase 2b retatrutide renal results; registers tersolisib kidney PK studyNov 13Weekly roundup, 10 itemsabemaciclibanastrozole
Lilly posts galunisertib PFS results in prostate cancer; registers new bimagrumab HFpEF trialNov 6Weekly roundup, 7 itemsbimagrumabEli LillyUpdated
Lilly-linked brain metastases trial posts results; two baricitinib studies completeOct 30Weekly roundup, 4 itemsabemaciclibadagrasibUpdated
Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Lilly posts two DC-806 Phase 1 DDI results; registers three new Phase 3 trialsOct 22Weekly roundup, 11 itemscetuximabdulaglutide
Lilly advances obesity and inflammation pipeline with new Phase 1 trials, Phase 2 updatesOct 9Weekly roundup, 10 itemsEli Lillyeloralintide
Lilly posts Phase 3 orforglipron results; registers new MDD trial and five other updatesOct 2Weekly roundup, 10 itemsbaricitinibbrenipatideUpdated
Lilly registers three new early trials: olomorasib in colorectal cancer, two obesity studiesSep 11Weekly roundup, 3 itemsEli Lillyeloralintide
Lilly posts orforglipron Phase 3 results; adds new early-phase studiesAug 14Weekly roundup, 6 itemsbaricitinibbrenipatide
Lilly-linked tirzepatide alopecia trial joins mazisotine results, eloralintide recruitingJul 31Weekly roundup, 3 itemsEli Lillyeloralintide
Lilly posts results for five completed Phase 1 studies, opens three new early trialsJul 17Weekly roundup, 8 itemsEli Lillyeloralintide